Skip to content

Cognitive control training for depression

Cognitive control training for depression: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13666367
Enrollment
60
Registered
2019-09-24
Start date
2017-10-01
Completion date
Unknown
Last updated
2019-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder Mental and Behavioural Disorders Major depressive disorder

Interventions

Allocation to groups was done with a computer-generated random number table. Arm 1 (Intervention) Cognitive Control Training: 18 sessions (twp per week) training execu

Sponsors

National Institute for Mental Health and Neuroscience (NIMHANS)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Major Depressive Disorder (as primary diagnosis) 2. Score of 17 or above on Beck’s Depression Inventory (BDI) 3. Age range of 18-50 years 4. Comprehension of written and spoken English/Hindi 5. Right handedness 6. Normal or corrected vision or hearing 7. Stable on medication dosage for one month

Exclusion criteria

Exclusion criteria: 1. History suggestive of neurological, neurosurgical conditions and /or history of head injury And/or mental retardation on clinical assessment 2. Diagnosis of schizophrenia, Bipolar Affective Disorder, Severe Depression with psychotic symptoms, Delusional disorder, current psychoactive substance abuse and/or dependence (except nicotine) 3. Any structured psychological intervention in the past 6 months 4. Any neurocognitive intervention and/or neuropsychological assessments 5. Have received ECT (in last 6 months)

Design outcomes

Primary

MeasureTime frame
Depression measured using Beck's Depression Inventory (BDI) at baseline and 9 weeks

Secondary

MeasureTime frame
1. Illness severity measured using the Clinical Global Index (CGI) at baseline and 9 weeks 2. Neuro-cognitive measures at baseline and 9 weeks: 2.1. Spatial Span 2.2. Digit Span (WMS III)

Countries

India

Contacts

Public ContactMeenakshi Banerjee
meenakshi.banerjee@gmail.com+91 (0)8197292827

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026